Welsis (WLSS) Net Margin (2022 - 2023)
Welsis' quarterly Net Margin came in at 663.2% in Q4 2023, down 40003.0% year-on-year from N/an in Q4 2022, and down 41350.0% quarter-over-quarter from 1.6% in Q3 2023.
Welsis has reported Net Margin for 2 years, with the latest figure at 663.2% in Q4 2023.
- For the quarter ending Q4 2023, Net Margin fell 40003.0% year-over-year to 663.2%; the trailing twelve-month figure through Sep 2024 stood at 3217.5% (down 308459.0% YoY), and the FY2024 full-year result was 3217.5%, down 308459.0% from the prior year.
- Net Margin for Q4 2023 stood at 663.2%, down from 1.6% in the prior quarter.
- The five-year high for Net Margin was 1.6% in Q3 2023, with the low at 663.2% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 29.21% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.06% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 19.57% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 18.66% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 13.15% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 13.80% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -8.93% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 0.61% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 3.68% |
| 10 | Welsis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -663.20% |
| Sep 30, 2023 | -1.60% |
| Jun 30, 2023 | -83.30% |
| Dec 31, 2022 | -263.17% |